Skip to main content
. 2017 Aug 23;8(14):2809–2815. doi: 10.7150/jca.18286

Figure 2.

Figure 2

Progression-free survival (PFS) to cetuximab-containing chemotherapy in overall patients (A), according to the status of microsatellite instability (B), and the location of the primary tumor (C).